The company
Sweden-based provider of a platform for new applications in cell-to-cell interactions and tissue.
The funding
Pixelgen Technologies, based in Stockholm, Sweden, announced $15.5M in Series B financing on August 20, 2026.
Participants include Flat Capital, Industrifonden, Navigare Ventures.